Also, upregulated UBE2C expression was significantly correlated with poor prognosis and disease free survival (DFS) of patients with ACC, KIRC, KIRP, LGG, LIHC, MESO, PAAD, Prostate adenocarcinoma (PRAD), THCA, Uterine corpus endometrial carcinoma (UCEC), and UVM (Figure 3B). Here, UBE2C is linked to pancreatic adenocarcinoma.